4D Molecular Therapeutics, Inc. (FDMT) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts FDMT Hot Sheet
Join SI Premium – FREE
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported Q1 EPS of ($0.86), in-line with the analyst estimate of ($0.86). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $529.67 thousand.
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
